126 related articles for article (PubMed ID: 9973186)
1. Neuroprotective activities of carvedilol and a hydroxylated derivative: role of membrane biophysical interactions.
Lysko PG; Lysko KA; Webb CL; Feuerstein G; Mason PE; Walter MF; Mason RP
Biochem Pharmacol; 1998 Dec; 56(12):1645-56. PubMed ID: 9973186
[TBL] [Abstract][Full Text] [Related]
2. Neuroprotective effects of carvedilol, a new antihypertensive, as a Na+ channel modulator and glutamate transport inhibitor.
Lysko PG; Webb CL; Feuerstein G
Neurosci Lett; 1994 Apr; 171(1-2):77-80. PubMed ID: 7916141
[TBL] [Abstract][Full Text] [Related]
3. A comparison of carvedilol and metoprolol antioxidant activities in vitro.
Lysko PG; Webb CL; Gu JL; Ohlstein EH; Ruffolo RR; Yue TL
J Cardiovasc Pharmacol; 2000 Aug; 36(2):277-81. PubMed ID: 10942172
[TBL] [Abstract][Full Text] [Related]
4. Neuroprotective effects of carvedilol, a new antihypertensive, at the N-methyl-D-aspartate receptor.
Lysko PG; Lysko KA; Webb CL; Feuerstein G
Neurosci Lett; 1992 Dec; 148(1-2):34-8. PubMed ID: 1300500
[TBL] [Abstract][Full Text] [Related]
5. SB 211475, a metabolite of carvedilol, a novel antihypertensive agent, is a potent antioxidant.
Yue TL; Mckenna PJ; Lysko PG; Gu JL; Lysko KA; Ruffolo RR; Feuerstein GZ
Eur J Pharmacol; 1994 Jan; 251(2-3):237-43. PubMed ID: 8149979
[TBL] [Abstract][Full Text] [Related]
6. Neuroprotective effects of carvedilol, a new antihypertensive agent, in cultured rat cerebellar neurons and in gerbil global brain ischemia.
Lysko PG; Lysko KA; Yue TL; Webb CL; Gu JL; Feuerstein G
Stroke; 1992 Nov; 23(11):1630-5; discussion 1635-6. PubMed ID: 1440712
[TBL] [Abstract][Full Text] [Related]
7. Carvedilol, a new vasodilator and beta adrenoceptor antagonist, is an antioxidant and free radical scavenger.
Yue TL; Cheng HY; Lysko PG; McKenna PJ; Feuerstein R; Gu JL; Lysko KA; Davis LL; Feuerstein G
J Pharmacol Exp Ther; 1992 Oct; 263(1):92-8. PubMed ID: 1357162
[TBL] [Abstract][Full Text] [Related]
8. Myocardial protection by the novel vasodilating beta-blocker, carvedilol: potential relevance of anti-oxidant activity.
Feuerstein GZ; Yue TL; Cheng HY; Ruffolo RR
J Hypertens Suppl; 1993 Jun; 11(4):S41-8. PubMed ID: 8104241
[TBL] [Abstract][Full Text] [Related]
9. Carvedilol, a novel vasodilating beta-blocker with the potential for cardiovascular organ protection.
Feuerstein GZ; Ruffolo RR
Eur Heart J; 1996 Apr; 17 Suppl B():24-9. PubMed ID: 8733068
[TBL] [Abstract][Full Text] [Related]
10. Amlodipine and carvedilol prevent cytotoxicity in cortical neurons isolated from stroke-prone spontaneously hypertensive rats.
Yamagata K; Ichinose S; Tagami M
Hypertens Res; 2004 Apr; 27(4):271-82. PubMed ID: 15127885
[TBL] [Abstract][Full Text] [Related]
11. Antioxidant properties of calcium antagonists related to membrane biophysical interactions.
Mason RP; Mak IT; Trumbore MW; Mason PE
Am J Cardiol; 1999 Aug; 84(4A):16L-22L. PubMed ID: 10480441
[TBL] [Abstract][Full Text] [Related]
12. A hydroxylated analog of the beta-adrenoceptor antagonist, carvedilol, affords exceptional antioxidant protection to postischemic rat hearts.
Kramer JH; Weglicki WB
Free Radic Biol Med; 1996; 21(6):813-25. PubMed ID: 8902527
[TBL] [Abstract][Full Text] [Related]
13. Carvedilol, a new antihypertensive drug with unique antioxidant activity: potential role in cerebroprotection.
Yue TL; Lysko PG; Barone FC; Gu JL; Ruffolo RR; Feuerstein GZ
Ann N Y Acad Sci; 1994 Nov; 738():230-42. PubMed ID: 7832432
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of heart mitochondrial lipid peroxidation by non-toxic concentrations of carvedilol and its analog BM-910228.
Santos DJ; Moreno AJ
Biochem Pharmacol; 2001 Jan; 61(2):155-64. PubMed ID: 11163330
[TBL] [Abstract][Full Text] [Related]
15. Perturbing effects of carvedilol on a model membrane system: role of lipophilicity and chemical structure.
Butler S; Wang R; Wunder SL; Cheng HY; Randall CS
Biophys Chem; 2006 Feb; 119(3):307-15. PubMed ID: 16243429
[TBL] [Abstract][Full Text] [Related]
16. Differential effects of short and prolonged exposure to carvedilol on voltage-dependent Na(+) channels in cultured bovine adrenal medullary cells.
Kajiwara K; Yanagita T; Nakashima Y; Wada A; Izumi F; Yanagihara N
J Pharmacol Exp Ther; 2002 Jul; 302(1):212-8. PubMed ID: 12065719
[TBL] [Abstract][Full Text] [Related]
17. Antioxidant and cytoprotective activities of the calcium channel blocker mibefradil.
Mason RP; Mak IT; Walter MF; Tulenko TN; Mason PE
Biochem Pharmacol; 1998 Jun; 55(11):1843-52. PubMed ID: 9714303
[TBL] [Abstract][Full Text] [Related]
18. Protective effects of carvedilol in the myocardium.
Feuerstein GZ; Bril A; Ruffolo RR
Am J Cardiol; 1997 Dec; 80(11A):41L-45L. PubMed ID: 9412541
[TBL] [Abstract][Full Text] [Related]
19. Carvedilol, a cardiovascular drug, prevents vascular smooth muscle cell proliferation, migration, and neointimal formation following vascular injury.
Ohlstein EH; Douglas SA; Sung CP; Yue TL; Louden C; Arleth A; Poste G; Ruffolo RR; Feuerstein GZ
Proc Natl Acad Sci U S A; 1993 Jul; 90(13):6189-93. PubMed ID: 8327499
[TBL] [Abstract][Full Text] [Related]
20. Incorporation of sodium channel blocking and free radical scavenging activities into a single drug, AM-36, results in profound inhibition of neuronal apoptosis.
Callaway JK; Beart PM; Jarrott B; Giardina SF
Br J Pharmacol; 2001 Apr; 132(8):1691-8. PubMed ID: 11309240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
